Author reply
| Main Authors: | Campbell, D., McGrady, M., Prior, D., Coller, J., Boffa, U., Shiel, L., Liew, D., Stewart, S., Reid, Christopher, Krum, H. |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/34927 |
Similar Items
Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: Potential relevance to the diastolic J-curve
by: Campbell, D., et al.
Published: (2014)
by: Campbell, D., et al.
Published: (2014)
Heart failure with preserved ejection fraction (HFpEF) is the predominant cause of incident chronic heart failure in contemporary Australia
by: Gong, F., et al.
Published: (2016)
by: Gong, F., et al.
Published: (2016)
NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)
by: McGrady, M., et al.
Published: (2013)
by: McGrady, M., et al.
Published: (2013)
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes
by: Campbell, D., et al.
Published: (2013)
by: Campbell, D., et al.
Published: (2013)
N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: Results of the SCReening Evaluation of the Evolution of New-Heart Failure Study (SCREEN-HF)
by: McGrady, M., et al.
Published: (2013)
by: McGrady, M., et al.
Published: (2013)
SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace
by: Boffa, U., et al.
Published: (2016)
by: Boffa, U., et al.
Published: (2016)
Prediction of heart failure by serum amino-terminal-pro-b-type natriuretic peptide (nt-probnp): an interim analysis of the screening evaluation of the evolution of new heart failure (screen-hf) study
by: Campbell, D., et al.
Published: (2015)
by: Campbell, D., et al.
Published: (2015)
Risk factor management in a contemporary Australian population at increased cardiovascular disease risk
by: Campbell, D., et al.
Published: (2018)
by: Campbell, D., et al.
Published: (2018)
Age-related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk
by: Gong, F.F., et al.
Published: (2020)
by: Gong, F.F., et al.
Published: (2020)
Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort
by: Gong, F., et al.
Published: (2018)
by: Gong, F., et al.
Published: (2018)
Age-specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure
by: Coller, J.M., et al.
Published: (2019)
by: Coller, J.M., et al.
Published: (2019)
Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort
by: Campbell, D., et al.
Published: (2019)
by: Campbell, D., et al.
Published: (2019)
Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
Re: Authors' reply to Stockwell and colleagues
by: Daube, Mike
Published: (2012)
by: Daube, Mike
Published: (2012)
Neuraminidase inhibitors for influenza complications: authors' reply
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)
Expectant management in pregnancies with ruptured membranes – Authors' reply
by: Morris, Jonathan M., et al.
Published: (2016)
by: Morris, Jonathan M., et al.
Published: (2016)
Reply.
by: Adams, L., et al.
Published: (2015)
by: Adams, L., et al.
Published: (2015)
In reply
by: Hillman, D., et al.
Published: (2010)
by: Hillman, D., et al.
Published: (2010)
The child support grant and adolescent risk of HIV infection in South Africa – Authors' reply
by: Cluver, L., et al.
Published: (2014)
by: Cluver, L., et al.
Published: (2014)
In reply
by: Ing, C., et al.
Published: (2015)
by: Ing, C., et al.
Published: (2015)
Comparison of vaccine efficacy must be based on good clinical data–Authors’ reply
by: Abdul Taib, Nur Asheila, et al.
Published: (2022)
by: Abdul Taib, Nur Asheila, et al.
Published: (2022)
Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)
by: Chan, Arlene, et al.
Published: (2016)
Reply: Letter to the editor, Cochrane rearranged
by: Beyer, W.E.P., et al.
Published: (2015)
by: Beyer, W.E.P., et al.
Published: (2015)
In reply
by: Said, J., et al.
Published: (2010)
by: Said, J., et al.
Published: (2010)
Reply
by: Spreckley, M., et al.
Published: (2009)
by: Spreckley, M., et al.
Published: (2009)
The self-sabotage of conservation: a reply to Manfredo et al.
by: Ives, Christopher D., et al.
Published: (2017)
by: Ives, Christopher D., et al.
Published: (2017)
Author Reply: Refers to du Toit, R. et al., Eye Health in East Timor
by: Finger, Robert, et al.
Published: (2008)
by: Finger, Robert, et al.
Published: (2008)
Keeping perspective on using tourism values for conservation - Reply to vianna
by: Catlin, J., et al.
Published: (2013)
by: Catlin, J., et al.
Published: (2013)
Mirazón Lahr et al. reply
by: Lahr, M., et al.
Published: (2016)
by: Lahr, M., et al.
Published: (2016)
Sakzewski et al. reply
by: Sakzewski, L., et al.
Published: (2012)
by: Sakzewski, L., et al.
Published: (2012)
Reply: Does the death knell toll for phlebotomy in NAFLD?
by: Adams, Leon, et al.
Published: (2015)
by: Adams, Leon, et al.
Published: (2015)
Authors’ reply: Comment on: Teaching metacognition in clinical decision-making using a novel mnemonic checklist: an exploratory study
by: Chew, KS, et al.
Published: (2017)
by: Chew, KS, et al.
Published: (2017)
Reply to Maslovat et al
by: Marinovic, W., et al.
Published: (2015)
by: Marinovic, W., et al.
Published: (2015)
Reply to Jones et al
by: Venkatesan, Sudhir, et al.
Published: (2017)
by: Venkatesan, Sudhir, et al.
Published: (2017)
Reply to 'gamma radiation measurement'
by: Ramli, Ahmad Termizi
Published: (2006)
by: Ramli, Ahmad Termizi
Published: (2006)
Conceptualizing generalizability: New contributions and a reply
by: Allen, L., et al.
Published: (2012)
by: Allen, L., et al.
Published: (2012)
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
by: Chan, C., et al.
Published: (2009)
by: Chan, C., et al.
Published: (2009)
The power of naming: A reply to McBride and Pates
by: Fraser, Suzanne, et al.
Published: (2005)
by: Fraser, Suzanne, et al.
Published: (2005)
Reply to ‘Mere algorithms can be demotivating’
by: Gagné, Marylène, et al.
Published: (2022)
by: Gagné, Marylène, et al.
Published: (2022)
BBC : Govt to reply to Dr M
Published: (2008)
Published: (2008)
Similar Items
-
Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: Potential relevance to the diastolic J-curve
by: Campbell, D., et al.
Published: (2014) -
Heart failure with preserved ejection fraction (HFpEF) is the predominant cause of incident chronic heart failure in contemporary Australia
by: Gong, F., et al.
Published: (2016) -
NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)
by: McGrady, M., et al.
Published: (2013) -
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes
by: Campbell, D., et al.
Published: (2013) -
N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: Results of the SCReening Evaluation of the Evolution of New-Heart Failure Study (SCREEN-HF)
by: McGrady, M., et al.
Published: (2013)